As such, future studies should investigate whether sustained TGFβ/ALK5 signalling acts upstream, downstream, or in parallel with the pro-inflammatory NF-κB pathway to promote tumour-initiating capacity. This evidence concerns the gene TGFBR1 and neoplasm.